PSMD4 and cancer: Proteome-wide TPP-TR of colorectal tumor cells identified the proteasome 26S subunit non-ATPase 4 (PSMD4) as a key target of atractylenolide I. Binding to PSMD4 enhanced immunoproteasome activity, increased antigen presentation, and improved the immune response to cancer cells [25].